Analysis: Quest Diagnostics Incorporated

US:DGX

Why is Quest Diagnostics Incorporated stock rising?

  • Corewell Health joint-venture launch and new Michigan lab ramp in early 2027.
  • Haystack MRD national commercial expansion through Flatiron integration and community oncology rollout later in 2026.
  • New California regional health-system Co-Lab win and hospital deal pipeline for the rest of 2026.

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Quest Diagnostics Incorporated and 4,900+ companies.

Sign in
5-day free pass. No card required.